1Kim JG, Graham DY. Helicobacter pylori infection and development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAIDs therapy. The misoprostol study group. Am J Gastroenterol,1994, 89:203-207.
2Wu CY, Poon SK, Chen GH, et al. Interaction between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding. Scand J Gastroenterol, 1999,34:234-237.
3Weil J, Colin-Jones D, Langnan M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ, 1995,310:827-830.
4Soll A . Pathogenesis of non-steroidal anti-inflammatory drugs-related upper gastrointestinal toxicity. Am J Med, 1998,105 (SA) :10S-16S.
5Cryer B, Redfem JS, Goldschmiedt M, et al. Effect of aging on gastric and duodenal mucosal prostaglandin concentrations in humans. Gastroenterology, 1992,102(4 Pt 1) :1118-1123.
6Aalykke C, Lauritsen JM, Hallas J, et al. Helicobacter pylori and risk of ulcer bleeding among user of non-steroidal anti-inflammatory drugs: a case-control study. Gastroenterology, 1999, 116: 1305-1309.
7McCarthy DM.Comparative toxicity of nonsteroidal anti-inflammatory drugs,1999(6A).
8Cappell MS;Schein JR.Diagnosis and treatment of nonsteroidal anti-inflammatory drug-associated upper gastrointestinal toxicity[J],2000(1).
9Raskin JB.Gastrointestinal effects of nonsteroidal anti-inflammatory therapy,1999.
10hawkey CJ.Nonsteroidal anti-inflammatory drug gastropathy[J],2000(2).
